Glioblastoma — Trials

Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

1,750 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 486
Recruiting: 258
Ph III recruiting: 13
Growth YoY: +41%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 151–156 of 156 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04868396	Patient-derived Glioma Stem Cell Organoids	active not recruiting	—	60	Maastricht Radiation OncologyOTHER	1	Nov 20, 2024	clinicaltrials
NCT01985087	A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70	active not recruiting	Phase 1 / Phase 2	18	University of LouisvilleOTHER	1	Oct 31, 2024	clinicaltrials